D. Jorstad

Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study.

N. Heerema, H. Sather, S. Hunger, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia : Children ’ s Oncology Group Study AALL 0031

M. Devidas, M. Trigg, W. Bowman, 2015 .

Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group Study AALL0031

N. Heerema, S. Hunger, M. Borowitz, 2014, Leukemia.

Philadelphia chromosome-negative very high-risk acute lymphoblastic leukemia in children and adolescents: results from Children’s Oncology Group Study AALL0031

N. Heerema, M. Devidas, A. Carroll, 2014, Leukemia.

Isolated late testicular relapse of B‐cell acute lymphoblastic leukemia treated with intensive systemic chemotherapy and response‐based testicular radiation: A Children's Oncology Group study

M. Loh, J. Gastier-Foster, B. Wood, 2018, Pediatric blood & cancer.

Improved Early Event Free Survival (EFS) in Children with Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) with Intensive Imatinib in Combination with High Dose Chemotherapy: Children’s Oncology Group (COG) Study AALL0031.

N. Heerema, H. Sather, S. Hunger, 2007 .

Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study.

N. Heerema, H. Sather, S. Hunger, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.